Compare Citius Pharmaceuticals Inc (CTXR) vs Marriott International Inc (MAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Marriott International Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Marriott International Inc trades at $349.88 (market cap $91.14B). The key difference: Marriott International Inc is far larger — about 4554.7× Citius Pharmaceuticals Inc's market cap, and Marriott International Inc pays a 0.84% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | MAR | |
|---|---|---|
Market Cap | $20.01M | $91.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $402.54 |
52-Week Low | $0.48 | $259.04 |
Enterprise Value | $16.23M | $108.45B |
Dividend Yield | — | 0.84% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →
